Nexalin Technology (NXL) Return on Capital Employed Growth (3y) (2025 - 2026)

Nexalin Technology (NXL) Return on Capital Employed Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -1,962.00
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 214.00
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 31.00
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 355.00
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -846.00
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -247.00
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 1,318.00
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 362.00
10 Nexalin Technology 8.72 Mn 6.01 Mn 13,133.00 -21,243.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -21,243.00
Dec 31, 2025 -17,928.00